Page last updated: 2024-10-24

mRNA cap binding

Definition

Target type: molecularfunction

Binding to a 7-methylguanosine (m7G) group or derivative located at the 5' end of an mRNA molecule. [GOC:dos]

mRNA cap binding is a crucial molecular process involved in the initiation and regulation of translation in eukaryotic cells. The 5' cap, a 7-methylguanosine (m7G) structure, is added to the 5' end of nascent mRNA transcripts during transcription. This cap serves as a recognition signal for various cellular factors that play essential roles in mRNA metabolism, including translation initiation. The key molecular function of mRNA cap binding is mediated by proteins known as cap-binding proteins (CBPs), such as eIF4E in eukaryotes. These CBPs possess a highly conserved cap-binding domain that specifically recognizes and binds to the m7G cap structure. Upon binding, CBPs facilitate the recruitment of other translation initiation factors, such as eIF4G, to form a complex at the 5' end of the mRNA. This complex then interacts with the 40S ribosomal subunit, promoting the assembly of the translation initiation complex. The interaction between CBPs and the mRNA cap is essential for efficient and accurate translation initiation. It prevents degradation of the mRNA by exonucleases, enhances mRNA stability, and facilitates the recruitment of the ribosome to the correct start codon. In addition to their role in translation initiation, CBPs are also involved in other processes related to mRNA metabolism, including mRNA export from the nucleus, mRNA splicing, and mRNA degradation. Overall, mRNA cap binding is a fundamental process in gene expression, ensuring the proper initiation and regulation of protein synthesis in eukaryotic cells.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Protein argonaute-2A protein argonaute-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UKV8]Homo sapiens (human)
Eukaryotic translation initiation factor 4EA eukaryotic translation initiation factor 4E that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06730]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
sulfaguanidinesulfaguanidine : A sulfonamide incorporating a guanidine moiety used to block the synthesis of folic acid; mostly used in veterinary medicine

Sulfaguanidine: A sulfanilamide antimicrobial agent that is used to treat enteric infections.
sulfonamide antibioticantiinfective agent
sulfanilamidesubstituted aniline;
sulfonamide;
sulfonamide antibiotic
antibacterial agent;
drug allergen;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
sulfisomidinesulfisomidine : A sulfonamide consisting of pyrimidine having methyl substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position.

Sulfisomidine: A sulfanilamide antibacterial agent.
pyrimidines;
sulfonamide;
sulfonamide antibiotic
antiinfective agent
uridine monophosphateuridine 5'-monophosphate : A pyrimidine ribonucleoside 5'-monophosphate having uracil as the nucleobase.

Uridine Monophosphate: 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.
pyrimidine ribonucleoside 5'-monophosphate;
uridine 5'-phosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
sirolimussirolimus : A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent.

Sirolimus: A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol
antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
6-mercapto-7-methylguanosine6-mercapto-7-methylguanosine: structure given in first source
cgp 57380CGP 57380: inhibits the mitogen-activated protein kinase-interacting kinase Mnk1pyrazolopyrimidine
7-methyl-GTPguanosine 5'-phosphate